Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis
Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segmen...
Gespeichert in:
Veröffentlicht in: | Journal of dermatology 2024-11, Vol.51 (11), p.1461-1469 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1469 |
---|---|
container_issue | 11 |
container_start_page | 1461 |
container_title | Journal of dermatology |
container_volume | 51 |
creator | Katsumi, Tatsuya Hayashi, Ryota Takei, Shingo Ansai, Osamu Takatsuka, Sumiko Takenouchi, Tatsuya Saito, Kyota Suda, Kazuaki Yoshihara, Kosuke Nagai, Takahiro Okuda, Shujiro Fukumoto, Takaya Ansai, Shin‐ichi Nakamura, Anna Katsuumi, Koji Ariizumi, Takashi Ogose, Akira Kawashima, Hiroyuki Abe, Riichiro |
description | Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas. |
doi_str_mv | 10.1111/1346-8138.17343 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3123549077</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3123165988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhzA1Z4tJLuv6I44Qb2pYvVQKh9mxN4knrKrEXO2m1v4E_jdMtRfRSXzyeefza0kPIW86OeV5rLsuqqLmsj7mWpXxGVg-d52TFZK0KUTJ9QF6ldM2YaBRnL8mBbMpaq0qsyO-fiDcwzDA5f0mvdm10lnqcY-hdG8MI69Rd3YL3ufxAf0S0YXQefIc09PTfjPYI0xwxUYtp6yakmxNZ0m1IbnI3btpR8JY6n08w_PcAtQ4ufebSa_KihyHhm_v9kFx8Oj3ffCnOvn_-uvl4VnRCKVlAg7otO8GaqtSi1FWLUFsLdqlk1_I8t8o2FfYCZNuhBt4okbsKpG61PCRH-9xtDL9mTJMZXepwGMBjmJORXEhVNkwv6PtH6HWYo8-_u6N4pZq6ztR6T3UxpBSxN9voRog7w5lZPJnFilmsmDtP-ca7-9y5HdE-8H_FZEDtgVs34O6pPPPt5HQf_AfYTp_Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3123165988</pqid></control><display><type>article</type><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</creator><creatorcontrib>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</creatorcontrib><description>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</description><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.17343</identifier><identifier>PMID: 39487562</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Antigens, CD34 - analysis ; Antigens, CD34 - metabolism ; CD34 ; CD34 antigen ; Collagen ; Female ; Humans ; hybrid schwannoma/neurofibroma ; LZTR1 ; Male ; Middle Aged ; Molecular modelling ; Mutation ; Neurilemmoma - diagnosis ; Neurilemmoma - pathology ; Neurofibroma - diagnosis ; Neurofibroma - metabolism ; Neurofibroma - pathology ; Neurofibromatoses ; Schwann cells ; schwannomatosis ; Skin Neoplasms - diagnosis ; Skin Neoplasms - metabolism ; Skin Neoplasms - pathology ; Tumors</subject><ispartof>Journal of dermatology, 2024-11, Vol.51 (11), p.1461-1469</ispartof><rights>2024 Japanese Dermatological Association.</rights><rights>Copyright © 2024 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</cites><orcidid>0000-0002-7582-8609 ; 0000-0001-6998-531X ; 0000-0001-9944-2228 ; 0000-0002-6818-944X ; 0000-0002-0373-5833 ; 0000-0001-7036-7084</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.17343$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.17343$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39487562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Katsumi, Tatsuya</creatorcontrib><creatorcontrib>Hayashi, Ryota</creatorcontrib><creatorcontrib>Takei, Shingo</creatorcontrib><creatorcontrib>Ansai, Osamu</creatorcontrib><creatorcontrib>Takatsuka, Sumiko</creatorcontrib><creatorcontrib>Takenouchi, Tatsuya</creatorcontrib><creatorcontrib>Saito, Kyota</creatorcontrib><creatorcontrib>Suda, Kazuaki</creatorcontrib><creatorcontrib>Yoshihara, Kosuke</creatorcontrib><creatorcontrib>Nagai, Takahiro</creatorcontrib><creatorcontrib>Okuda, Shujiro</creatorcontrib><creatorcontrib>Fukumoto, Takaya</creatorcontrib><creatorcontrib>Ansai, Shin‐ichi</creatorcontrib><creatorcontrib>Nakamura, Anna</creatorcontrib><creatorcontrib>Katsuumi, Koji</creatorcontrib><creatorcontrib>Ariizumi, Takashi</creatorcontrib><creatorcontrib>Ogose, Akira</creatorcontrib><creatorcontrib>Kawashima, Hiroyuki</creatorcontrib><creatorcontrib>Abe, Riichiro</creatorcontrib><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</description><subject>Adult</subject><subject>Antigens, CD34 - analysis</subject><subject>Antigens, CD34 - metabolism</subject><subject>CD34</subject><subject>CD34 antigen</subject><subject>Collagen</subject><subject>Female</subject><subject>Humans</subject><subject>hybrid schwannoma/neurofibroma</subject><subject>LZTR1</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular modelling</subject><subject>Mutation</subject><subject>Neurilemmoma - diagnosis</subject><subject>Neurilemmoma - pathology</subject><subject>Neurofibroma - diagnosis</subject><subject>Neurofibroma - metabolism</subject><subject>Neurofibroma - pathology</subject><subject>Neurofibromatoses</subject><subject>Schwann cells</subject><subject>schwannomatosis</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - metabolism</subject><subject>Skin Neoplasms - pathology</subject><subject>Tumors</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhzA1Z4tJLuv6I44Qb2pYvVQKh9mxN4knrKrEXO2m1v4E_jdMtRfRSXzyeefza0kPIW86OeV5rLsuqqLmsj7mWpXxGVg-d52TFZK0KUTJ9QF6ldM2YaBRnL8mBbMpaq0qsyO-fiDcwzDA5f0mvdm10lnqcY-hdG8MI69Rd3YL3ufxAf0S0YXQefIc09PTfjPYI0xwxUYtp6yakmxNZ0m1IbnI3btpR8JY6n08w_PcAtQ4ufebSa_KihyHhm_v9kFx8Oj3ffCnOvn_-uvl4VnRCKVlAg7otO8GaqtSi1FWLUFsLdqlk1_I8t8o2FfYCZNuhBt4okbsKpG61PCRH-9xtDL9mTJMZXepwGMBjmJORXEhVNkwv6PtH6HWYo8-_u6N4pZq6ztR6T3UxpBSxN9voRog7w5lZPJnFilmsmDtP-ca7-9y5HdE-8H_FZEDtgVs34O6pPPPt5HQf_AfYTp_Z</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Katsumi, Tatsuya</creator><creator>Hayashi, Ryota</creator><creator>Takei, Shingo</creator><creator>Ansai, Osamu</creator><creator>Takatsuka, Sumiko</creator><creator>Takenouchi, Tatsuya</creator><creator>Saito, Kyota</creator><creator>Suda, Kazuaki</creator><creator>Yoshihara, Kosuke</creator><creator>Nagai, Takahiro</creator><creator>Okuda, Shujiro</creator><creator>Fukumoto, Takaya</creator><creator>Ansai, Shin‐ichi</creator><creator>Nakamura, Anna</creator><creator>Katsuumi, Koji</creator><creator>Ariizumi, Takashi</creator><creator>Ogose, Akira</creator><creator>Kawashima, Hiroyuki</creator><creator>Abe, Riichiro</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7582-8609</orcidid><orcidid>https://orcid.org/0000-0001-6998-531X</orcidid><orcidid>https://orcid.org/0000-0001-9944-2228</orcidid><orcidid>https://orcid.org/0000-0002-6818-944X</orcidid><orcidid>https://orcid.org/0000-0002-0373-5833</orcidid><orcidid>https://orcid.org/0000-0001-7036-7084</orcidid></search><sort><creationdate>202411</creationdate><title>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</title><author>Katsumi, Tatsuya ; Hayashi, Ryota ; Takei, Shingo ; Ansai, Osamu ; Takatsuka, Sumiko ; Takenouchi, Tatsuya ; Saito, Kyota ; Suda, Kazuaki ; Yoshihara, Kosuke ; Nagai, Takahiro ; Okuda, Shujiro ; Fukumoto, Takaya ; Ansai, Shin‐ichi ; Nakamura, Anna ; Katsuumi, Koji ; Ariizumi, Takashi ; Ogose, Akira ; Kawashima, Hiroyuki ; Abe, Riichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2553-a9e7b4c2096472476bea8ddad76be3cb19e7d5d96ef2a3bce7a19529e75a37b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antigens, CD34 - analysis</topic><topic>Antigens, CD34 - metabolism</topic><topic>CD34</topic><topic>CD34 antigen</topic><topic>Collagen</topic><topic>Female</topic><topic>Humans</topic><topic>hybrid schwannoma/neurofibroma</topic><topic>LZTR1</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular modelling</topic><topic>Mutation</topic><topic>Neurilemmoma - diagnosis</topic><topic>Neurilemmoma - pathology</topic><topic>Neurofibroma - diagnosis</topic><topic>Neurofibroma - metabolism</topic><topic>Neurofibroma - pathology</topic><topic>Neurofibromatoses</topic><topic>Schwann cells</topic><topic>schwannomatosis</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - metabolism</topic><topic>Skin Neoplasms - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katsumi, Tatsuya</creatorcontrib><creatorcontrib>Hayashi, Ryota</creatorcontrib><creatorcontrib>Takei, Shingo</creatorcontrib><creatorcontrib>Ansai, Osamu</creatorcontrib><creatorcontrib>Takatsuka, Sumiko</creatorcontrib><creatorcontrib>Takenouchi, Tatsuya</creatorcontrib><creatorcontrib>Saito, Kyota</creatorcontrib><creatorcontrib>Suda, Kazuaki</creatorcontrib><creatorcontrib>Yoshihara, Kosuke</creatorcontrib><creatorcontrib>Nagai, Takahiro</creatorcontrib><creatorcontrib>Okuda, Shujiro</creatorcontrib><creatorcontrib>Fukumoto, Takaya</creatorcontrib><creatorcontrib>Ansai, Shin‐ichi</creatorcontrib><creatorcontrib>Nakamura, Anna</creatorcontrib><creatorcontrib>Katsuumi, Koji</creatorcontrib><creatorcontrib>Ariizumi, Takashi</creatorcontrib><creatorcontrib>Ogose, Akira</creatorcontrib><creatorcontrib>Kawashima, Hiroyuki</creatorcontrib><creatorcontrib>Abe, Riichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katsumi, Tatsuya</au><au>Hayashi, Ryota</au><au>Takei, Shingo</au><au>Ansai, Osamu</au><au>Takatsuka, Sumiko</au><au>Takenouchi, Tatsuya</au><au>Saito, Kyota</au><au>Suda, Kazuaki</au><au>Yoshihara, Kosuke</au><au>Nagai, Takahiro</au><au>Okuda, Shujiro</au><au>Fukumoto, Takaya</au><au>Ansai, Shin‐ichi</au><au>Nakamura, Anna</au><au>Katsuumi, Koji</au><au>Ariizumi, Takashi</au><au>Ogose, Akira</au><au>Kawashima, Hiroyuki</au><au>Abe, Riichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2024-11</date><risdate>2024</risdate><volume>51</volume><issue>11</issue><spage>1461</spage><epage>1469</epage><pages>1461-1469</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><abstract>Schwannomas consist of both high‐cellularity regions (Antoni A area) and hypocellular regions (Antoni B area) in histopathological findings. Neurofibromas characteristically consist of CD34 positive spindle cells with thin, wavy, nuclei and wavy collagen bands. Previous reports have described segments of schwannomas with neurofibroma features as hybrid tumors, although hybrid tumors were diagnosed based on partial CD34 positivity in many previous reports. On the other hand, the Antoni B area of some schwannomas was reported to be positive for CD34. Therefore, the definition of a hybrid tumor has not been clear. The objective of this study was to determine whether only CD34 positive findings in schwannomas could be used to define a hybrid tumor. In the analysis of our patient with schwannomatosis caused by a novel LZTR1 germline mutation, part of the tumor had CD34 positive hypocellular regions. These regions contained no thin, wavy, nuclei, indicating an Antoni B area. Laser microdissection was used to investigate the genetic background and differences in molecular mechanisms between CD34 positive and CD34 negative regions. All mutations identified in CD34 positive regions were also found in CD34 negative regions. Our data could not clear the genetic background of Antoni B which was CD34 positive area. We then reviewed the pathologies of 66 sporadic schwannomas. Histopathological examinations of all schwannomas revealed the absence of thin, wavy, nuclei and wavy collagen bands, and no hybrid tumors were found in any of the cases. Ten of 66 patients were randomly selected for CD34 immunostaining and positivity was found in all cases. Our data suggest that it is difficult to distinguish schwannomas by staining for CD34 alone, as Antoni B areas can also be positive for CD34. Therefore, CD34 staining alone should not be used to diagnose hybrid tumors in patients with schwannomas.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39487562</pmid><doi>10.1111/1346-8138.17343</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-7582-8609</orcidid><orcidid>https://orcid.org/0000-0001-6998-531X</orcidid><orcidid>https://orcid.org/0000-0001-9944-2228</orcidid><orcidid>https://orcid.org/0000-0002-6818-944X</orcidid><orcidid>https://orcid.org/0000-0002-0373-5833</orcidid><orcidid>https://orcid.org/0000-0001-7036-7084</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0385-2407 |
ispartof | Journal of dermatology, 2024-11, Vol.51 (11), p.1461-1469 |
issn | 0385-2407 1346-8138 1346-8138 |
language | eng |
recordid | cdi_proquest_miscellaneous_3123549077 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adult Antigens, CD34 - analysis Antigens, CD34 - metabolism CD34 CD34 antigen Collagen Female Humans hybrid schwannoma/neurofibroma LZTR1 Male Middle Aged Molecular modelling Mutation Neurilemmoma - diagnosis Neurilemmoma - pathology Neurofibroma - diagnosis Neurofibroma - metabolism Neurofibroma - pathology Neurofibromatoses Schwann cells schwannomatosis Skin Neoplasms - diagnosis Skin Neoplasms - metabolism Skin Neoplasms - pathology Tumors |
title | Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T15%3A35%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reevaluating%20hybrid%20neurofibroma/schwannoma:%20Predominance%20of%20schwannoma%20features%20despite%20CD34%20positivity%20and%20initial%20neurofibroma%20diagnosis&rft.jtitle=Journal%20of%20dermatology&rft.au=Katsumi,%20Tatsuya&rft.date=2024-11&rft.volume=51&rft.issue=11&rft.spage=1461&rft.epage=1469&rft.pages=1461-1469&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.17343&rft_dat=%3Cproquest_cross%3E3123165988%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3123165988&rft_id=info:pmid/39487562&rfr_iscdi=true |